Interactions among gender, age, hypertension and C-reactive protein in coronary vasospasm

European Journal of Clinical Investigation

Volumn 40, Issue 12, 2010, Pages 1094-1103

  Hung, Ming Yow ^a,b   Hsu, Kuang Hung ^c   Hung, Ming Jui ^a   Cheng, Chi Wen ^a   Cherng, Wen Jin ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Age; Coronary vasospasm; Gender; High sensitivity C reactive protein; Hypertension

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY SPASM; DISEASE COURSE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROVOCATION TEST; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING;

AGE FACTORS; C-REACTIVE PROTEIN; CORONARY VASOSPASM; FEMALE; HUMANS; HYPERTENSION; MALE; MODELS, BIOLOGICAL; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SMOKING; TAIWAN;

EID: 78649439976     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02360.x     Document Type: Article

References (39)

1. Yasue H, Nakagawa H, Itoh T, Harada E, Mizuno Y. Coronary artery spasm--clinical features, diagnosis, pathogenesis, and treatment. J Cardiol 2008;51:2-17.
2. Kalsner S, Richards R. Coronary arteries of cardiac patients are hyperreactive and contain stores of amines: a mechanism for coronary spasm. Science 1984;223:1435-7.
3. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993;87:76-9.
4. Roeters van Lennep JE, Westerveld HT, Erkelens DW, Van Der Wall EE. Risk factors for coronary heart disease: implications of gender. Cardiovasc Res 2002;53:538-49.
5. Roger VL, Farkouh ME, Weston SA, Reeder GS, Jacobsen SJ, Zinsmeister AR et al. Sex differences in evaluation and outcome of unstable angina. JAMA 2000;283:646-52.
6. Murase Y, Yamada Y, Hirashiki A, Ichihara S, Kanda H, Watarai M et al. Genetic risk and gene-environment interaction in coronary artery spasm in Japanese men and women. Eur Heart J 2004;25:970-7.
7. Hung MJ, Cherng WJ, Yang NI, Cheng CW, Li LF. Relation of high-sensitivity C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease. Am J Cardiol 2005;96:1484-90.
8. Hung MJ, Cherng WJ, Cheng CW, Li LF. Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease. Am J Cardiol 2006;97:1429-34.
9. Lakoski SG, Cushman M, Palmas W, Blumenthal R, D'Agostino RB Jr, Herrington DM. The relationship between blood pressure and C-reactive protein in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 2005;46:1869-74.
10. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F et al ; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
11. Sato I, Tomita M, Ohe T, Haze K, Shimomura K. Age-related changes of clinical features and prevalences of coronary risk factors in Japanese patients with vasospastic angina. Chest 1986;89:12-9.
12. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97.
13. Sharaf BL, Williams DO, Miele NJ, McMahon RP, Stone PH, Bjerregaard P et al. A detailed angiographic analysis of patients with ambulatory electrocardiographic ischemia: results from the Asymptomatic Cardiac Ischemia Pilot (ACIP) study angiographic core laboratory. J Am Coll Cardiol 1997;29:78-84.
14. Miyao Y, Kugiyama K, Kawano H, Motoyama T, Ogawa H, Yoshimura M et al. Diffuse intimal thickening of coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 2000;36:432-7.
15. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M et al. Centers for Disease Control and Prevention. American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
16. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994;331:417-24.
17. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-3.
18. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997;17:1121-7.
19. Cook NR, Buring JE, Ridker PM. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med 2006;145:21-9.
20. Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K et al. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex. J Hypertens 2008;26:26-34.
21. Blake GJ, Rifai N, Buring JE, Ridker PM. Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation 2003;108:2993-9.
22. Choi H, Cho DH, Shin HH, Park JB. Association of high sensitivity C-reactive protein with coronary heart disease prediction, but not with carotid atherosclerosis, in patients with hypertension. Circ J 2004;68:297-303.
23. LeBlanc AJ, Shipley RD, Kang LS, Muller-Delp JM. Age impairs Flk-1 signaling and NO-mediated vasodilation in coronary arterioles. Am J Physiol Heart Circ Physiol 2008;295:H2280-8.
24. Ota Y, Kugiyama K, Sugiyama S, Ohgushi M, Matsumura T, Doi H et al. Impairment of endothelium- dependent relaxation of rabbit aortas by cigarette smoke extract--role of free radicals and attenuation by captopril. Atherosclerosis 1997;131:195-202.
25. Welsh P, Woodward M, Rumley A, Lowe G. Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study. Br J Haematol 2008;141:852-61.
26. Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 2008;359:1897-908.
27. Kung CF, Luscher TF. Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension 1995;25:194-200.
28. Tschudi MR, Luscher TF. Age and hypertension differently affect coronary contractions to endothelin-1, serotonin, and angiotensins. Circulation 1995;91:2415-22.
29. Fukuda N, Hu WY, Satoh C, Nakayama M, Kishioka H, Kubo A et al. Contribution of synthetic phenotype on the enhanced angiotensin II-generating system in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens 1999;17:1099-107.
30. Sueda S, Kohno H, Fukuda H, Ochi N, Kawada H, Hayashi Y et al. Frequency of provoked coronary spasms in patients undergoing coronary arteriography using a spasm provocation test via intracoronary administration of ergonovine. Angiology 2004;55:403-11.
31. Bertrand ME, LaBlanche JM, Tilmant PY, Thieuleux FA, Delforge MR, Carre AG et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 1982;65:1299-306.
32. Coma-Canella I, Castano S, Macias A, Calabuig J, Artaiz M. Ergonovine test in angina with normal coronary arteries. Is it worth doing it? Int J Cardiol 2006;107:200-6.
33. Mortensen ES, Rognum TO, Straume B, Jorgensen L. Evidence at autopsy of spasm in the distal right coronary artery in persons with coronary heart disease dying suddenly. Cardiovasc Pathol 2007;16:336-43.
34. Morel O, Sauer F, Imperiale A, Cimarelli S, Blondet C, Jesel L et al. Importance of inflammation and neurohumoral activation in Takotsubo cardiomyopathy. J Card Fail 2009;15:206-13.
35. Angelini P. Transient left ventricular apical ballooning: A unifying pathophysiologic theory at the edge of Prinzmetal angina. Catheter Cardiovasc Interv 2008;71:342-52.
36. Kounis NG. Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm? Int J Cardiol 2006;110:7-14.
37. Jenkins NP, Keevil BG, Hutchinson IV, Brooks NH. Beta-blockers are associated with lower C-reactive protein concentrations in patients with coronary artery disease. Am J Med 2002;112:269-74.
38. Hung MJ, Cherng WJ, Cheng CW, Yang NI. Effect of antispastic agents (calcium antagonists and/or isosorbide dinitrate) on high-sensitivity C-reactive protein in patients with coronary vasospastic angina pectoris and no hemodynamically significant coronary artery disease. Am J Cardiol 2005;95:84-7.
39. De Cesare N, Cozzi S, Apostolo A, Berti M, Carbucicchio C, Selva A et al. Facilitation of coronary spasm by propranolol in Prinzmetal's angina: fact or unproven extrapolation? Coron Artery Dis 1994;5:323-30.